List view / Grid view


Cancer risk linked to DNA ‘wormholes’

19 February 2015 | By The Institute of Cancer Research

Single-letter genetic variations within parts of the genome once dismissed as ‘junk DNA’ can increase cancer risk through wormhole-like effects on far-off genes, new research shows...

Genticel presents pipeline development at EUROGIN congress held in Seville, Spain

6 February 2015 | By Genticel

Genticel announces that data obtained with ProCervix, its lead therapeutic vaccine, will be presented in the EUROGIN (EUropean Research Organisation on Genital Infection and Neoplasia) 2015 Congress taking place at the FIBES II Conference and Exhibition Centre in Seville, Spain on February 4 – 7...

TxCell reports revenues for 2014 and updates on upcoming milestones

5 February 2015 | By TxCell

TxCell, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, reports its revenues as of December 31, 2014 and updates on forthcoming milestones...

Rigontec GmbH Appoints Dr. Christian Schetter as CEO

5 February 2015 | By Rigontec GmbH

Rigontec GmbH, a privately held biopharmaceutical company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases, announces the appointment of Dr. Christian Schetter as CEO...